Surface plasmon resonance biosensors for early troponin detection

Clin Chim Acta. 2024 Apr 4:118670. doi: 10.1016/j.cca.2024.118670. Online ahead of print.ABSTRACTAcute myocardial infarction (AMI) is one of the life-threatening causes that decrease blood flow to the heart, leading to increased mortality and related complications. Recently, the measure of blood concentration of cardiac biomarkers has been suggested to overcome the limitations of electrocardiography (ECG) analyses for early diagnosis of this disease. Troponins, especially cardiac troponin I and cardiac troponin T, with high sensitivity and specificity, are considered the gold standards in myocardial diagnosis. Recently, the use of new biosensors such as surface plasmon resonance (SPR) for early detection of these biomarkers has been greatly appreciated. Due to the rapid, sensitive, real-time, and label-free detection of SPR-based biosensors, they can be applied for selective and nonspecific absorption that is intended to be used as an in situ cardiac biosensor. Here, we exclusively discussed the updated developments of these valuable predictors for the possible occurrence of AMI detected by SPR.PMID:38582245 | DOI:10.1016/j.cca.2024.118670
Source: International Journal of Clinical Chemistry - Category: Chemistry Authors: Source Type: research